Peptides ArchiveAll Peptide Resources in One Archive
Research Use OnlyScientific, regulatory and product-reference information only. No medical advice or human-use recommendation.Compliance Hub

Peptide Technical Analysis

Selank vs Semax Lyophilized Shelf Life and Storage

Compare Selank and Semax lyophilized stability, degradation routes, storage controls, and the HPLC-MS evidence needed to assign a defensible shelf life.

Selank Semax archive searchResearch Use OnlyNeuro Peptides

There is no scientifically defensible answer to “How long do Selank and Semax last?” without knowing the exact sequence form, formulation, vial closure and storage history. Online tables often assign both peptides the same shelf life because both arrive as small white lyophilized cakes. Their backbones are different, and lyophilization does not stop every degradation pathway. It reduces molecular mobility and water activity; it does not erase oxygen, residual moisture, light exposure or adsorption.

Selank is commonly defined as the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, derived from the tuftsin sequence with a Pro-Gly-Pro extension. Semax is commonly defined as the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, related to an ACTH(4–7) fragment with the same C-terminal Pro-Gly-Pro extension. The practical stability difference begins with those residues. Semax contains methionine, which creates an oxidation pathway that Selank does not share. Selank contains basic lysine and arginine residues, giving it a different charge profile and interaction with counterions, glass and chromatographic media.

Sequence labels still need verification. “Semax” can be confused with N-acetylated analogues in literature and catalogs. Acetylation changes the expected mass, charge and proteolytic behavior. Published work on acetyl-Semax stability cannot be used as a direct shelf-life certificate for non-acetylated Semax. The same caution applies to salt forms and unspecified stabilizers.

What degradation looks like in the data

For Semax, methionine oxidation should be included in the LC-MS target list. A +16 Da mass shift is a useful first indicator, but retention and fragmentation help assign the site. Further oxidation can occur under stronger stress. Light, dissolved oxygen, peroxides in excipients and repeated air exchange after opening can accelerate this route. A clean visual appearance does not rule it out.

Both peptides can produce hydrolytic or enzymatic fragments after dissolution. Deamidation is not the obvious primary concern for the commonly stated sequences because they lack Asn and Gln, but terminal and backbone cleavage still matter. Short hydrophilic fragments may elute early and be missed by a gradient designed only around the parent. UV sensitivity can also be uneven: Semax contains aromatic residues that provide stronger absorbance at some wavelengths, while Selank may be less responsive. Comparing area loss between the two using one uncalibrated UV method can therefore mislead.

An intact mass result at time zero establishes identity, not shelf life. A stability study needs a validated, stability-indicating LC method capable of separating the parent from relevant degradants, plus MS assignment for significant new peaks. Peptide content, appearance, pH after reconstitution and particulate observations can supplement the primary assay. The acceptance criteria and time points should be fixed before the study begins.

Storage questions a COA cannot answer alone

Residual moisture is one of the most overlooked variables. Two visually sound cakes from different lyophilization cycles may age differently if primary drying or stopper conditions changed. Karl Fischer water data and batch trend records are more useful than photographs. Oxygen in the headspace also matters more for methionine-containing Semax. Nitrogen backfill can reduce exposure, but only a validated process and closure system make that claim meaningful.

Practical handling for analytical and preclinical work

Store unopened lyophilized vials sealed, dry and protected from light at the batch-specific validated temperature. Avoid repeated warming and cooling of the entire stock. When a vial is removed from cold storage, allow it to equilibrate while sealed so atmospheric moisture does not condense onto the cake.

After dissolution, use a buffer and pH supported by the experimental protocol and by recovery testing. Prepare working aliquots in low-binding vessels where appropriate. Limit headspace exchange and unnecessary agitation, particularly for Semax oxidation control. Define a short-term hold time from actual LC data instead of copying a universal “refrigerated for X days” claim. Microbial control and chemical stability are separate questions; a clear solution can fail either one.

For comparative stability, place Selank and Semax in matched formulations and containers, then test them with methods calibrated for each analyte. Do not infer that a larger Semax UV peak means more material remains. Report percent parent, absolute assay and identified degradants. Current published information on these research peptides is far thinner than for approved therapeutic peptides, and large, standardized stability datasets are lacking. That limitation should appear in procurement decisions.

Supplier screening starts with exact identity, manufacturing route, counterion, residual moisture, quantitative peptide content and full stability conditions. Ask for raw chromatograms from the claimed expiry point. A time-zero-only COA cannot support a 24-month shelf life. PubMed searches for Semax proteolytic stability, acetyl-Semax and Selank peptide analysis provide useful literature entry points, while forensic reports also show why seized or unofficial preparations cannot be assumed to match their labels.

Selank and Semax are genuine amino-acid peptides, but their similar length does not make their shelf lives interchangeable. This guidance is for Research Use Only quality control and preclinical sample handling. It contains no route, dose or human-administration recommendation.

Primary records and verification routes

Use the primary paper, current regulator record or lot-linked analytical file for the specific claim it supports. Search results are routes to evidence, not evidence by themselves.

Research Use Only. No dosing, administration, compounding or human-use guidance is provided.